kuvura kanseri y'ibihaha bito

Kuvura kanseri y'ibihaha itari nto (NSCLC) amahitamo aratandukanye kandi biterwa na stade, subtype, nibintu byabarwayi. Ubuvuzi busanzwe burimo kubaga, kuvura imirasire, chimiotherapie, kuvura intego, hamwe na immunotherapie, bikunze gukoreshwa hamwe. Aka gatabo karasobanura buri buryo burambuye, bugufasha gusobanukirwa nibishoboka no gufata ibyemezo byuzuye mugisha inama hamwe nitsinda ryanyu ryita kubuzima.Kumva Kanseri yibihaha itari mito (NSCLC) NSCLC niki?Kanseri y'ibihaha itari ntoya (NSCLC) ni ubwoko bwa kanseri y'ibihaha ikunze kugaragara, bingana na 80-85% by'abanduye kanseri y'ibihaha. Nijambo ryumutaka ririmo subtypes nyinshi, ikunze kugaragara cyane ni adenocarcinoma, kanseri y'udukoko twa kanseri, na kanseri nini ya selile. Icyiciro cya NSCLC Icyiciro cya NSCLC ningirakamaro muguhitamo uburyo bwiza bwo kuvura. Icyiciro kigenwa nubunini n’aho ikibyimba giherereye, niba cyarakwirakwiriye hafi ya lymph node, ndetse niba cyaratewe no kugera ku ngingo za kure. Intego ni ugukuraho ikibyimba hamwe na lymph node hafi aho ishobora kuba irimo kanseri ya kanseri. Lobectomy: Gukuraho lobe yose yibihaha. Pneumonectomy: Gukuraho ibihaha byose. Kurwanya Wedge: Gukuraho agace gato, kameze nk'igiti cy'ibihaha. Segmentectomy: Gukuraho igice cyibihaha, kikaba kinini kuruta kwifata ariko kikaba gito kuruta lobectomy.Icyitonderwa: Kubaga ntibishobora kuba amahitamo kubarwayi bafite NSCLC yateye imbere cyangwa abafite ubundi buzima bwubuzima butuma kubaga bishobora guteza akaga. Irashobora gukoreshwa mu kuvura NSCLC muburyo butandukanye: Ubuvuzi bwo hanze bwimirasire (EBRT): Imirasire itangwa mumashini hanze yumubiri. Ubuvuzi bwa stereotactique yumubiri (SBRT): Uburyo busobanutse neza bwa EBRT butanga urugero runini rwimirasire mukarere gato. Akenshi ikoreshwa kuri kanseri y'ibihaha hakiri kare mugihe kubagwa bidashoboka. Brachytherapy: Ibikoresho bya radiyo bishyirwa mubibyimba cyangwa hafi yacyo. Ubuvuzi bwa radiyoyasi burashobora gukoreshwa wenyine cyangwa bufatanije nubundi buvuzi, nka chimiotherapie. Turi kuri Shandong Baofa Ikigo Cyubushakashatsi Kanseri sobanukirwa n'akamaro ko guhuza imiti kubisubizo byiza. Baofa numuyobozi mubuvuzi bwa kanseri ihuriweho. ChimiotherapieChemotherapie ikoresha imiti yica kanseri ya kanseri mumubiri. Bikunze gukoreshwa mu kuvura NSCLC yateye imbere cyangwa kugirango kanseri itazongera kubaho nyuma yo kubagwa. Imiti isanzwe ya chimiotherapie kuri NSCLC irimo: Cisplatin Carboplatin Pemetrexed Docetaxel PaclitaxelChemotherapie itangwa mubisanzwe, hamwe nibihe byo kuvurwa bikurikirwa nibiruhuko. Ingaruka zinyuranye zirashobora gutandukana bitewe nibiyobyabwenge byakoreshejwe numurwayi kugiti cye. Ubuvuzi bugamije Ubuvuzi bugamije gukoresha imiti yibasira molekile zihariye zigira uruhare mu mikurire ya kanseri no kubaho. Iyi miti akenshi ikora neza kandi ifite ingaruka nke ugereranije na chimiotherapie. Ubuvuzi bugamije ni busanzwe kubarwayi bafite ihindagurika ryimiterere. Intego rusange zirimo: EGFR: Epidermal Gukura Ibintu Byakirwa ALK: Lymphoma Kinase ROS1: ROS1 Proto-Oncogene Yakira Tyrosine Kinase BRAF: B-Raf Proto-Oncogene, Serine / Threonine Kinase NTRK: Neurotrophic Tyrosine Receptor KinaseUrugero rw'imiti igamije kuvura ikoreshwa muri NSCLC harimo: Gefitinib (Iressa) Erlotinib (Tarceva) Afatinib (Gilotrif) Osimertinib (Tagrisso) Crizotinib (Xalkori) Ceritinib (Zykadia) Alectinib (Alecensa) mutation.ImmunotherapyImmunotherapy ikoresha imiti ifasha umubiri wumubiri kurwanya kanseri. Iyi miti irashobora guhagarika poroteyine zibuza umubiri kwirinda indwara ya kanseri. Imiti isanzwe ikingira indwara ya NSCLC irimo: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Atezolizumab (Tecentriq) Durvalumab (Imfinzi) Immunotherapy irashobora gukoreshwa wenyine cyangwa ifatanije na chimiotherapie cyangwa ubundi buvuzi. Ingaruka mbi zirashobora kuba zirimo umunaniro, kurwara uruhu, no gutwika ingingo zitandukanye. Ubuvuzi bwa NSCLC na StageStage I NSCLC Kubaga akenshi nubuvuzi bwibanze kuri Stage I NSCLC. SBRT irashobora gusuzumwa niba umurwayi atari umukandida wo kubaga.Icyiciro cya II NSCLCUmuti wo mu cyiciro cya II NSCLC mubisanzwe harimo kubagwa bikurikirwa na chimiotherapie. Imiti ivura imirasire irashobora kandi gukoreshwa. Icyiciro cya III NSCLCUmuvuzi wicyiciro cya III NSCLC iragoye kandi irashobora kuba ikubiyemo guhuza kubaga, chimiotherapie, hamwe nubuvuzi bwimirasire. Immunotherapy irashobora kandi gukoreshwa nyuma ya chemoradiation mubihe bimwe na bimwe.Icyiciro cya IV NSCLCUmuti wo mu cyiciro cya IV NSCLC yibanda ku kugenzura imikurire ya kanseri no kugabanya ibimenyetso. Amahitamo arashobora kubamo chimiotherapie, kuvura intego, immunotherapy, hamwe no kuvura imirasire. Guhitamo kwivuza biterwa nibiranga kanseri nubuzima bwumurwayi muri rusange.Igeragezwa rya Clinical Ibigeragezo byubuvuzi ni ubushakashatsi bwubushakashatsi bupima uburyo bushya bwo kuvura kanseri. Abarwayi bafite NSCLC barashobora kwemererwa kwitabira ibizamini byamavuriro. Vugana na muganga wawe kugirango umenye byinshi kubyerekeye ibizamini byo kwa muganga kandi niba bikubereye. Shandong Baofa Ikigo Cyubushakashatsi cya Kanseri kwiyemeza gukora ubushakashatsi bivuze ko tugumye kumurongo wambere wubuvuzi bushya, rimwe na rimwe binyuze mubigeragezo byamavuriro. Gufata ibyemezo byo kuvura Guhitamo uburyo bwiza bwo kuvura NSCLC nicyemezo kitoroshye kigomba gufatwa mubyumvikanyeho nitsinda ryanyu ryita kubuzima. Ibintu bigomba kwitabwaho harimo icyiciro na subtype ya kanseri, ubuzima bwumurwayi muri rusange, nibyo akunda. Ntutindiganye kubaza ibibazo no gushaka igitekerezo cya kabiri nibikenewe.Ibiciro byo Kumenyekanisha no KurokokaIbipimo byo kurokoka kuri NSCLC biratandukanye bitewe na kanseri, ubuvuzi bwakiriwe, nibindi bintu. Kumenya hakiri kare no kuvura birashobora kongera amahirwe yo kubaho. Icyiciro cyimyaka 5 yo Kurokoka Icyiciro I 68-92% Icyiciro cya II 53-60% Icyiciro cya III 13-36% Icyiciro cya IV Ntibiri 10% * Inkomoko: Sosiyete y'Abanyamerika Kanseri (www.cancer.org) Kubana na NSCLCLiving hamwe na NSCLC birashobora kuba ingorabahizi, ariko hariho ibikoresho byinshi byafasha abarwayi nimiryango yabo guhangana. Ibikoresho birimo amatsinda atera inkunga, serivisi zubujyanama, na gahunda zifasha amafaranga.